Biohaven
BHVN • NYSE
Biohaven is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Vladimir Coric, with a market cap of $1.3B.
Market Cap$1.3B
Employees239.0
CEOVladimir Coric
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Biohaven FAQ
Common questions about Biohaven
Biohaven is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $8.3M.
Biohaven has approximately 239 employees.